Wake Forest Alzheimer's Disease Clinical Core
This is an observational study looking at Alzheimer's Disease, Mild Cognitive Impairment (MCI), and prediabetes. Researchers are collecting information and samples to better understand how Alzheimer's develops, especially before symptoms appear. They hope to find new ways to detect the disease early and develop new treatments. The study will measure changes in your cognitive (thinking and memory) abilities over 5 years. You can join if you are at least 55 years old, regardless of your current cognitive health. The study is particularly interested in including people from underserved communities.
- Study design
- This is an observational study with a planned enrollment of 850 participants. It is not testing a specific intervention or drug.
- What's involved
- The study involves collecting cognitive data, human samples (blood, cerebrospinal fluid), medical and family history, and neuroimaging data. This information will be stored indefinitely for future research.
- Compensation
- Not stated in the trial record.
- Follow-up
- Changes in cognitive measures will be assessed over 5 years.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Wake Forest Alzheimer's Disease Clinical Core
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Jeff Williamson, MD · PRINCIPAL_INVESTIGATOR · Wake Forest University Health Sciences
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Change in performance on cognitive measures.5 years
Cognitive measure such as memory, verbal fluency and executive function will be assessed annually, either by phone or in person depending on group.